Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 28.93 USD 2.44%
Market Cap: 11.3B USD

Wall Street
Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 38.07 USD with a low forecast of 17.17 USD and a high forecast of 141.75 USD.

Lowest
Price Target
17.17 USD
41% Downside
Average
Price Target
38.07 USD
32% Upside
Highest
Price Target
141.75 USD
390% Upside
Moderna Inc Competitors:
Price Targets
ADCT
ADC Therapeutics SA
131% Upside
ALKS
Alkermes Plc
59% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
23% Upside
AMGN
Amgen Inc
5% Upside
VCEL
Vericel Corp
51% Upside
URGN
Urogen Pharma Ltd
61% Upside
IDYA
IDEAYA Biosciences Inc
51% Upside
CRNX
Crinetics Pharmaceuticals Inc
71% Upside

Revenue
Forecast

Revenue Estimate
Moderna Inc

For the last 7 years the compound annual growth rate for Moderna Inc's revenue is 48%. The projected CAGR for the next 3 years is -11%.

48%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Moderna Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Moderna Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRNA's stock price target?
Price Target
38.07 USD

According to Wall Street analysts, the average 1-year price target for MRNA is 38.07 USD with a low forecast of 17.17 USD and a high forecast of 141.75 USD.

What is Moderna Inc's Revenue forecast?
Projected CAGR
-11%

For the last 7 years the compound annual growth rate for Moderna Inc's revenue is 48%. The projected CAGR for the next 3 years is -11%.

Back to Top